Search dm+d | This VMP cannot be matched against our prescribing data.
| Name | Lamivudine 300mg / Tenofovir disoproxil 245mg / Doravirine 100mg tablets |
| BNF code | 0503010ASAAAAAA |
| Virtual Therapeutic Moiety | Lamivudine + Tenofovir disoproxil + Doravirine |
| Abbreviated name | Lamivudine 300mg/Tenofovir disoproxil 245mg/Doravirine 100mg |
| Basis of preferred name | Other |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | tablet |
| Unit dose unit of measure | tablet |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Lamivudine |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 300.000 |
| Strength value numerator unit | mg |
| Virtual Product Ingredient | |
| Ingredient | Tenofovir disoproxil |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 245.000 |
| Strength value numerator unit | mg |
| Virtual Product Ingredient | |
| Ingredient | Doravirine |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 100.000 |
| Strength value numerator unit | mg |
| Ontology Drug Form & Route | |
| Form & Route | tablet.oral |
| Dose Form | |
| Formulation | Oral tablet |
| Drug Route | |
| Route | Oral |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Delstrigo 100mg/300mg/245mg tablets (Merck Sharp & Dohme (UK) Ltd) | |
| Virtual Medicinal Product Packs | |
| Lamivudine 300mg / Tenofovir disoproxil 245mg / Doravirine 100mg tablets 30 tablet | |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.